APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has published a notice regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Demat Account. This applies to shareholders who have not claimed or received dividends for seven consecutive years or more. The company has communicated individually with affected shareholders and uploaded their details on the company website. Physical share certificates will be cancelled upon transfer, while demat shares will be moved via corporate action. Shareholders have until 10th August 2026 to claim their unclaimed dividends and prevent share transfer. Both unclaimed dividends and transferred shares can be claimed back from IEPF Authority using web form IEPF-5.
This is a routine regulatory compliance filing under IEPF rules. It does not directly impact the company's financials or operations. Affected shareholders who do not act by the deadline will see their shares transferred to IEPF and may need to follow a refund process to reclaim them.